Geneva, June 8 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125755) titled 'Study on the role of MDH2 lactylation in tumor microcirculation abnormalities' on May 31.
Study Type: Observational study
Study Design:
Factorial
Primary Sponsor: Suzhou Municipal Hospital
Condition:
cancer
Intervention:
Liver cancer group:None
lung cancer group:None
colorectal cancer group:None
Recruitment Status: Recruiting
Phase: 0
Date of First Enrollment: 2026-06-01
Target Sample Size: Liver cancer group:3;lung cancer group:3;colorectal cancer group:3;Renal cancer group:0;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=325320
Published by...